Lactate Ester and Benzaldehyde Antimicrobial Composition

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antimicrobial agents for cosmetics and foodstuffs face challenges in providing broad-spectrum activity against microorganisms like Aspergillus and Staphylococcus, while being toxicologically acceptable, stable, inexpensive, and easily formulable, with a lack of clear correlation between chemical structure and biological activity, leading to inefficient testing and unpredictable performance in cosmetic formulations.

Innovation Solution

A composition comprising lactate esters in combination with benzaldehyde derivatives and aromatic alcohols or acids, which synergistically enhances antimicrobial activity against a wide range of microorganisms, including Aspergillus species, Candida, and Staphylococcus, without using biocides like parabens or formaldehyde donors.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional antimicrobial agents are used to provide broad-spectrum activity, then antimicrobial efficacy is improved, but toxicological acceptability and skin tolerability deteriorate

Engineering Contradiction:
Improveantimicrobial efficacyVSAvoidtoxicological acceptability
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent combines multiple antimicrobial agents (lactate esters, benzaldehyde derivatives, aromatic alcohols, and aromatic acids) into a composite formulation. This combination approach allows the synergistic effect of multiple substances to achieve broad-spectrum antimicrobial activity while distributing the toxicological burden across multiple components, each at lower individual concentrations, thereby improving overall toxicological acceptability.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention creates a composite antimicrobial system comprising multiple chemical entities with different mechanisms of action. This composite approach enables coverage against a wider range of microorganisms (Gram-positive and Gram-negative bacteria, yeast, molds) while maintaining better safety profile through the diversified chemical structure and distributed functional responsibilities among components.

Inventive Principle:
Principle #40Composite materials

2Stability of the object's composition

If antimicrobial agents are selected to be stable in cosmetic formulations, then formulation stability is improved, but antimicrobial activity against specific microorganisms deteriorates

Engineering Contradiction:
Improveformulation stabilityVSAvoidantimicrobial activity
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent merges antimicrobial agents with complementary functional molecules (aromatic alcohols, aromatic acids) that enhance stability in cosmetic formulations. The combination includes substances that act as chelating agents, antioxidants, or buffer components, which stabilize the formulation while the lactate esters and benzaldehyde derivatives maintain antimicrobial activity, achieving both stability and efficacy simultaneously.

Inventive Principle:
Principle #5Merging (Combining)

3Loss of time

If chemical structure-activity correlation is established to guide selection, then development time is reduced, but current knowledge is insufficient to predict performance

Engineering Contradiction:
Improvedevelopment timeVSAvoidpredictability of performance
Core Design Contradiction:
Loss of timeVSLoss of information

Solution Approach 1:

The patent performs preliminary combination of antimicrobial agents with stabilizing and synergistic molecules before final formulation. By pre-combining lactate esters with benzaldehyde derivatives, aromatic alcohols, and aromatic acids in defined ratios, the invention creates ready-to-use formulations that demonstrate both stability and antimicrobial activity, reducing the need for extensive trial-and-error testing while maintaining predictive capability through established combination protocols.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS10639253B2Compositions
Publication Date: 2020.05.05 SYMRISE GMBH & CO KG
  • US10639253B2 patent drawing
  • US10639253B2 patent drawing
  • US10639253B2 patent drawing

AI summary

Suggested is a composition comprising(a) at least one lactate ester and(b1) at least one second compound selected from the group encompassing benzaldehyde derivatives, aromatic aldehydes and aromatic acids.